Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma
2017; Elsevier BV; Volume: 1; Issue: 23 Linguagem: Inglês
10.1182/bloodadvances.2017006866
ISSN2473-9537
AutoresTineke Casneuf, Xu Steven Xu, Homer Adams, Amy Axel, Christopher Chiu, Imran Khan, Tahamtan Ahmadi, Xiaoyu Yan, Sagar Lonial, Torben Plesner, Henk M. Lokhorst, Niels W.C.J. van de Donk, Pamela L. Clemens, A. Kate Sasser,
Tópico(s)Immune Cell Function and Interaction
Referência(s)